NLRP3 and Alzheimer disease: Given its role in driving inflammation and neuronal injury, the NLRP3 inflammasome represents a promising therapeutic target in AD, with ongoing research into inhibitors that could potentially mitigate neuroinflammation and slow disease progression [62].